Keyphrases
Breakthrough Disease
25%
Breakthrough Infection
25%
COVID-19
100%
Delta Virus
25%
High Dose
25%
High-dose Influenza Vaccine
25%
Immune Response
25%
Immunization
25%
Immunogenicity
25%
K18-hACE2 Mice
50%
Low-dose Formulation
50%
Low-magnitude
25%
Lung Infection
25%
Lung Pathology
25%
Modified mRNA
25%
MRNA Vaccine
100%
MRNA-1273
25%
MRNA-1273 Vaccine
25%
Neutralizing Antibodies
25%
Pneumonia
25%
Protective Behavior
100%
Serum Titers
25%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
25%
Spike Protein
75%
T Cell Response
25%
Vaccination
25%
Vaccine Breakthrough
25%
Viral Variants
25%
Virus
25%
Virus Variants
25%
Weight Loss
25%
Wuhan
25%
Immunology and Microbiology
Breakthrough Infection
25%
COVID-19
25%
Drug Megadose
50%
Hepatitis Delta Virus
25%
Immune Response
25%
Immunogenicity
25%
Infection
25%
Low Drug Dose
75%
Neutralizing Antibody
25%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
75%
T Cell
25%
Titer
25%
Virus
50%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
25%
Hepatitis Delta Virus
25%
Immunogenicity
25%
Infection
25%
K 18
50%
Lung Infection
25%
Messenger RNA
75%
mRNA Vaccine
100%
Neutralizing Antibody
25%
SARS Coronavirus
100%